Abstract
Pseudomonas aeruginosa and Acinetobacter baumannii are two of the main bacteria responsible for nosocomial infections; both organisms are resistant to several classes of antibiotics making their infections very difficult to treat. Moreover, they possess a remarkable ability to form biofilms, which further enhances their antimicrobial resistance. Both organisms coordinate their formation of biofilms and their expression of virulence factors through quorum sensing, a system that regulates gene expression at high cell densities and that plays a key role in the establishment of bacterial infections. Hence, interfering with these quorum-sensing systems has been proposed as an alternative to traditional antibiotics for the eradication of bacterial infections. In this review, we describe the quorum sensing systems of both organisms, the way they coordinate the formation of biofilms, the recent advances in biofilm disruption by quorum sensing interference, and the advantages and limitations of the implementation of these novel therapeutic options in the clinic.
Keywords: Quorum quenching, Homoserine lactone, In vivo biofilm models, Stress response, Resistance.
Graphical Abstract
Current Topics in Medicinal Chemistry
Title:Exploiting Quorum Sensing Inhibition for the Control of Pseudomonas aeruginosa and Acinetobacter baumannii Biofilms
Volume: 17 Issue: 17
Author(s): Israel Castillo-Juarez, Luis Esau Lopez-Jacome, Gloria Soberon-Chavez, Maria Tomas, Jintae Lee, Paulina Castaneda-Tamez, Ivan Angelo Hernandez-Barragan, Martha Yumiko Cruz-Muniz, Toshinari Maeda, Thomas K. Wood and Rodolfo Garcia-Contreras*
Affiliation:
- Department of Microbiology and Parasitology, Faculty of Medicine, UNAM, P.O. Box: 04890, Mexico City,Mexico
Keywords: Quorum quenching, Homoserine lactone, In vivo biofilm models, Stress response, Resistance.
Abstract: Pseudomonas aeruginosa and Acinetobacter baumannii are two of the main bacteria responsible for nosocomial infections; both organisms are resistant to several classes of antibiotics making their infections very difficult to treat. Moreover, they possess a remarkable ability to form biofilms, which further enhances their antimicrobial resistance. Both organisms coordinate their formation of biofilms and their expression of virulence factors through quorum sensing, a system that regulates gene expression at high cell densities and that plays a key role in the establishment of bacterial infections. Hence, interfering with these quorum-sensing systems has been proposed as an alternative to traditional antibiotics for the eradication of bacterial infections. In this review, we describe the quorum sensing systems of both organisms, the way they coordinate the formation of biofilms, the recent advances in biofilm disruption by quorum sensing interference, and the advantages and limitations of the implementation of these novel therapeutic options in the clinic.
Export Options
About this article
Cite this article as:
Castillo-Juarez Israel, Lopez-Jacome Esau Luis, Soberon-Chavez Gloria, Tomas Maria, Lee Jintae, Castaneda-Tamez Paulina, Hernandez-Barragan Angelo Ivan, Cruz-Muniz Yumiko Martha, Maeda Toshinari, Wood K. Thomas and Garcia-Contreras Rodolfo*, Exploiting Quorum Sensing Inhibition for the Control of Pseudomonas aeruginosa and Acinetobacter baumannii Biofilms, Current Topics in Medicinal Chemistry 2017; 17 (17) . https://dx.doi.org/10.2174/1568026617666170105144104
DOI https://dx.doi.org/10.2174/1568026617666170105144104 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Immunopathology of Brucella Infection
Recent Patents on Anti-Infective Drug Discovery Alkaloids: An Emerging Antibacterial Modality Against Methicillin Resistant Staphylococcus aureus
Current Pharmaceutical Design Anti-Pathogenic Efficacy and Molecular Targets of a Polyherbal Wound- Care Formulation (Herboheal) Against Staphylococcus aureus
Infectious Disorders - Drug Targets Uveitis in Rheumatic Diseases
Current Rheumatology Reviews Natural Products Towards the Discovery of Potential Future Antithrombotic Drugs
Current Pharmaceutical Design Bacterial Protein Microarrays for Diagnosis of Infectious Diseases
Current Immunology Reviews (Discontinued) Production and Application of Bacteriophage and Bacteriophage-Encoded Lysins
Recent Patents on Biotechnology Ceftriaxone-Vancomycin Drug Toxicity Reduction by VRP 1020 in Mus musculus Mice
Current Clinical Pharmacology Heart Failure in South America
Current Cardiology Reviews The Human Microbiome Project, Personalized Medicine and the Birth of Pharmacomicrobiomics
Current Pharmacogenomics and Personalized Medicine CA125: An Increasingly Promising Biomarker of Heart Failure
Current Pharmaceutical Design Malignant Hypertension: A Rare Problem or is it Underdiagnosed?
Current Vascular Pharmacology Acute Tonsillitis
Infectious Disorders - Drug Targets DNA Microarrays - An Armory for Combating Infectious Diseases in the New Century
Infectious Disorders - Drug Targets Effect of Treatment with Caspofungin on the Diagnosis of Fungal Infections by Gamma Scintigraphy
Current Radiopharmaceuticals Daptomycin: A Review of Properties, Clinical Use, Drug Delivery and Resistance
Mini-Reviews in Medicinal Chemistry Optimization of Drug Safety Profile in Inflammatory Bowel Disease Through a Personalized Approach
Current Drug Targets Candida parapsilosis Secreted Lipase as an Important Virulence Factor
Current Protein & Peptide Science The Impact of Methodology and Confounding Variables on the Association Between Major Depression and Coronary Heart Disease: Review and Recommendations
Current Psychiatry Reviews N-Containing Ag(I) and Hg(II) Complexes: A New Class of Antibiotics
Current Topics in Medicinal Chemistry